Christopher Gibson - 03 Feb 2025 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role
Chief Executive Officer, Director
Signature
/s/ Kyle Nelson, attorney-in-fact
Issuer symbol
RXRX
Transactions as of
03 Feb 2025
Net transactions value
-$40,375
Form type
4
Filing time
05 Feb 2025, 16:50:17 UTC
Previous filing
13 Jan 2025
Next filing
07 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A Common Stock Award $0 +525,283 +71% $0.000000 1,261,916 03 Feb 2025 Direct F1
transaction RXRX Class A Common Stock Award $0 +16,809 +1.3% $0.000000 1,278,725 03 Feb 2025 Direct F2
transaction RXRX Class A Common Stock Tax liability $40,375 -5,569 -0.44% $7.25 1,273,156 03 Feb 2025 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RXRX Stock Option (Right to Buy) Award $0 +1,050,567 $0.000000 1,050,567 03 Feb 2025 Class A Common Stock 1,050,567 $7.25 Direct F4
holding RXRX Stock Option (Right to Buy) 813,600 03 Feb 2025 Class A Common Stock 0 $8.55 Direct F5
holding RXRX Stock Option (Right to Buy) 399,002 03 Feb 2025 Class A Common Stock 0 $11.40 Direct F6
holding RXRX Stock Option (Right to Buy) 5,436 03 Feb 2025 Class A Common Stock 0 $11.40 Direct
holding RXRX Stock Option (Right to Buy) 282,500 03 Feb 2025 Class A Common Stock 0 $2.48 Direct F7
holding RXRX Class B Common Stock 5,976,700 03 Feb 2025 Class A Common Stock 0 $0.000000 Direct F8
holding RXRX Class B Common Stock 486,000 03 Feb 2025 Class A Common Stock 0 $0.000000 by LAHWRAN-3 LLC F8, F9
holding RXRX Class B Common Stock 388,000 03 Feb 2025 Class A Common Stock 0 $0.000000 by LAHWRAN-4 LLC F8, F10
holding RXRX Class B Common Stock 67,875 03 Feb 2025 Class A Common Stock 0 $0.000000 by Gibson Family Trust F8, F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This RSU vests as to one one-sixteenth (1/16th) of the units subject the RSU on May 15, 2025 and every three months thereafter.
F2 This RSU vested immediately upon the grant date.
F3 Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units.
F4 The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2025, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
F5 The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
F6 The option, originally for 416,350 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
F7 The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
F8 Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
F9 The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager.
F10 The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager.
F11 The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee.